ROP — Roche Holding AG Share News
0.000.00%
Last trade - 00:00- CH₣254.44bn
- CH₣276.23bn
- CH₣61.52bn
Roche, Medicines Patent Pool sign deal to expand access to influenza drug
Brief: Astrazeneca Collaborates With Roche Diagnostics Asia Pacific To Help Accelerate Sustainable Ecosystem For Advanced Pathology In Breast And Lung Cancer
Brief: FDA Approves Genentech’S Tecentriq For Adjuvant Muscle-Invasive Bladder Cancer With Ctdna-Guided Treatment
Brief: FDA Approves Atezolizumab For Adjuvant Treatment Of Muscle Invasive Bladder Cancer In Some Patients
Brief: Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology
Roche gets second European approval for Alzheimer's test
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Switzerland's Roche agrees to acquire US-based PathAI
Zealand Pharma posts smaller-than-expected Q1 loss as obesity drugs advance (updated)
Zealand Pharma posts smaller-than-expected Q1 loss as obesity drugs advance
Brief: Roche Enters To Acquire Pathai For $750 Million Upfront
Recursion falls after quarterly revenue miss
Factbox: Global drugmakers rush to boost US presence as tariff threat looms
Brief: Roche Holding To Present Data On Ophthalmology Portfolio At Arvo 2026
Brief: Zealand Pharma, Roche To Advance petrelintide To Phase 3 Trials For Chronic Weight Management
Regeneron beats quarterly estimates on strong Dupixent demand (updated)
Regeneron beats quarterly results estimates on strong Dupixent demand